Where are shares of Evogene Ltd (EVGN) falling in the biotech space after falling -11.02% this week?

A 41 rating places Evogene Ltd (EVGN) near the middle of the biotech industry according to InvestorsObserver. Evogene Ltd’s score of 41 means it scores higher than 41% of sector stocks. Evogene Ltd also received an overall rating of 39, which puts it above 39% of all shares. Biotechnology is ranked 69th out of 148 industries.

EVGN has an overall score of 39. Find out what this means for you and get the rest of the ranking on EVGN!

What do these notes mean?

Stock analysis can be difficult. There are tons of numbers and ratios out there, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We categorize most of our scores by percentiles to make it easier for investors to understand. A score of 39 means the stock is more attractive than 39% of stocks. These rankings allow you to easily compare stocks and see what the strengths and weaknesses of a given company are. This allows you to find the stocks with the best short-term and long-term growth prospects in seconds. The combined score incorporates technical and fundamental analysis to provide a comprehensive view of a stock’s performance. Investors who then want to focus on analyst rankings or valuations can view separate scores for each section.

What’s going on with Evogene Ltd shares today?

Evogene Ltd (EVGN) stock is trading at $1.05 at 1:28 p.m. on Tuesday, April 26, a loss of -$0.05, or -4.55% from the previous closing price of 1, $10. The stock has traded between $1.05 and $1.10 so far today. Today the volume is low. So far, 132,171 shares have been traded with an average volume of 235,732 shares. Click here for the full Evogene Ltd stock report.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter